VivoSeq
Nephrology

Peritoneal Dialysis (PD)

0

Pipeline Programs↗

0

Active Trials↗

3

Companies Involved↗

Peritoneal Dialysis (PD) is an early-stage landscape with 0 programs across 3 companies. The most active players are Iperboreal Pharma Srl, Vifor Fresenius Medical Care Renal Pharma, Fresenius Medical Care Deutschland GmbH.

Intelligence

Pipeline Metrics

Competitive Density

0/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

83/100

Attrition Rate

14/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

I

Iperboreal Pharma Srl

0 programs

PreclinicalV

Vifor Fresenius Medical Care Renal Pharma

0 programs

PreclinicalF

Fresenius Medical Care Deutschland GmbH

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

7

clinical trials

Completed5 · 71%
Unknown status1 · 14%
Withdrawn1 · 14%

Clinical Trials

Trial Activity

7 trials

Non-interventional Study to Investigate the Short and Long Term Real-life Safety, Effectiveness, and Adherence of Velphoro® in Patients With Hyperphosphataemia Undergoing Haemodialysis (HD) or Peritoneal Dialysis (PD)
Completed·VVifor Fresenius Medical Care Renal Pharma·N/A·NCT02687594·1,400 enrolled
Clinical Evaluation of Low Sodium Peritoneal Dialysis (PD) Solution on Hypertensive Patients Treated With PD
Completed·FFresenius Medical Care Deutschland GmbH·Phase 3·NCT00794326·140 enrolled
Pioglitazone Attenuates Dysmetabolism in Peritoneal Dialysis (PD) Patients
Completed·HHuashan Hospital·N/A·NCT01258322·70 enrolled
Effect of an L-carnitine-containing Peritoneal Dialysis (PD) Solution on Insulin Sensitivity in Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD)
Completed·IIperboreal Pharma Srl·Phase 2·NCT00755456·35 enrolled
Effects of a Nurse-Led Comprehensive Intervention on Frailty and Self-Management Behaviors in Patients Undergoing Peritoneal Dialysis
Completed·Henan University·Preclinical·NCT07677085·72 enrolled
Effect of an L-Carnitine-Containing Peritoneal Dialysis (PD) Solution on Insulin Sensitivity in Diabetic Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD)
Withdrawn·IIperboreal Pharma Srl·Phase 2·NCT00755404
Anti-Oxidant Effect on Peritoneal Membrane in Peritoneal Dialysis (PD) Patients
Unknown status·EEwha Womans University·Phase 4·NCT01111422·66 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)